Ionis Pharmaceuticals and Genuity Science have partnered on the discovery of up to 20 novel targets rooted in the underlying biology of a range of diseases.
“I’m convinced that the way Genuity Science is working is the future of genomic research.”
Hear from Leo Saheljio, MD, VP of Translational Medicine on the announcement of the collaboration, and why Ionis chose Genuity Science as a partner for this work.
Watch now
TARGET AND DRUG DISCOVERY
Based on the causal biology of disease
PORTFOLIO OPTIMIZATION
Validate programs and focus investment
CLINICAL TRIALS
Optimize for success and patient benefit
BIOMARKER DISCOVERY
Identify rapid progressors and severity subtypes for patient stratification
Genuity Science brings purpose-driven data and genomic know-how to catalyze insights and drive better drug discovery decisions.
We combine retrospective and prospective population-based disease-specific datasets powered for statistical significance to create a robust picture of disease providing stronger signals for clearer conclusions.
Our high-quality whole genome sequence approach is coupled with deep phenotypic data fuelling our advanced analysis - taking insight a step further.
Our expertise in massive, population-scale datasets and deep learning methods is enhanced by expertise in the industry’s only data analysis platform built for population-scale genomics.
Longitudinal insight illuminates disease progression over time for a more comprehensive picture of the disease.
Our services span study design, cohort sourcing, sample preparation, sequencing, and advanced analytics applied to genotypic and phenotypic data. All of these activities are supported by the world-class scientific expertise of the Genuity Science team.
Next Generation Sequencing
Data Analysis
We are conducting a growing number of research studies across the island of Ireland and beyond. The potential for genomics to transform healthcare is immense. We are only just beginning to scratch the surface. Watch this video to see why this research is so important to participants such as Dr. Rory Mooney.
Our studies are focused on complex diseases where there is an indication of a genetic or inherited link to the condition. For these studies, eligible participants who would like to participate are enrolled in the research directly through their clinicians at the hospital site in Ireland where they are treated.
How You Can Help
